Intelligene Inc. (TPEX:7832)
Taiwan
· Delayed Price · Currency is TWD 11.95
-0.10 (-0.83%)
Last updated: Dec 5, 2025, 11:08 AM CST
Intelligene Company Description
Intelligene Inc. engages in the development of RNA gene therapy drugs for infectious diseases.
The company uses siRNA based drugs to develop the treatment of pandemics and influenza. The company was founded in 2023 and is headquartered in Taipei, Taiwan.
Intelligene Inc.
| Country | Taiwan |
| Founded | 2023 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 20 |
| CEO | Xianlong Huang |
Contact Details
Address: 14F.-6, No. 508, Sec. 7 Taipei, 115011 Taiwan | |
| Phone | 886 2 2655 8825 |
| Website | intelli-gene.com |
Stock Details
| Ticker Symbol | 7832 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Xianlong Huang | Chief Executive Officer |
| Shixian Huang | Chief Financial Officer |
| Peiyi Song | Chief Operating Officer |